BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32426271)

  • 1. Serum STIP1, a Novel Indicator for Microvascular Invasion, Predicts Outcomes and Treatment Response in Hepatocellular Carcinoma.
    Ma XL; Tang WG; Yang MJ; Xie SH; Wu ML; Lin G; Lu RQ
    Front Oncol; 2020; 10():511. PubMed ID: 32426271
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prophylactic TACE on 5-year survival of patients with hepatocellular carcinoma after hepatectomy.
    He S; Fan X; Ma H; Xiaerfuhazi H; Rehato A; Feng J; Shi X; He F
    Oncol Lett; 2019 Aug; 18(2):1824-1830. PubMed ID: 31423250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma.
    Ma XL; Jiang M; Zhao Y; Wang BL; Shen MN; Zhou Y; Zhang CY; Sun YF; Chen JW; Hu B; Gong ZJ; Zhang X; Cao Y; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    Ann Surg Oncol; 2018 Jun; 25(6):1686-1694. PubMed ID: 29626309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis.
    Yang J; Liang H; Hu K; Xiong Z; Cao M; Zhong Z; Yao Z; Deng M
    Cancer Cell Int; 2021 Feb; 21(1):92. PubMed ID: 33549093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of serum STIP1 in HCC and AFP-negative HCC.
    Sun H; Liu N; Lou J
    Lab Med; 2024 May; ():. PubMed ID: 38780206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postintervention Interleukin-6 (IL-6) Level, Rather than the Pretreatment or Dynamic Changes of IL-6, as an Early Practical Marker of Tumor Response in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
    Wu Y; Fan W; Xue M; Zhong B; Zhang S; Wang Y; Yao W; Zhao Y; Li J
    Oncologist; 2019 Dec; 24(12):e1489-e1495. PubMed ID: 31249138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum T Cell Immunoglobulin Mucin 3 Predicts Worse Prognosis in Hepatocellular Carcinoma Patients Undergoing Transcatheter Arterial Chemoembolization.
    Li J; Wang J
    Med Sci Monit; 2022 Jul; 28():e935326. PubMed ID: 35859350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
    Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
    Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
    Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
    Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety.
    Wei W; Jian PE; Li SH; Guo ZX; Zhang YF; Ling YH; Lin XJ; Xu L; Shi M; Zheng L; Chen MS; Guo RP
    Cancer Commun (Lond); 2018 Oct; 38(1):61. PubMed ID: 30305149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma.
    Shirabe K; Toshima T; Kimura K; Yamashita Y; Ikeda T; Ikegami T; Yoshizumi T; Abe K; Aishima S; Maehara Y
    Liver Int; 2014 Jul; 34(6):937-41. PubMed ID: 24393295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
    Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
    J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new laboratory-based algorithm to predict microvascular invasion and survival in patients with hepatocellular carcinoma.
    Zhu Y; Xu D; Zhang Z; Dong J; Zhou Y; Zhang WW; Hong L; Zhu WW
    Int J Surg; 2018 Sep; 57():45-53. PubMed ID: 30075291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pathological response after preoperative transcatheter arterial chemoembolization (TACE) on incidences of microvascular invasion and early tumor recurrence in hepatocellular carcinoma: a multicenter propensity score matching analysis.
    Yang Y; Dang Z; Lu P; Qian Y; Lin K; Pan Z; Lau WY; Zhou W
    Hepatobiliary Surg Nutr; 2022 Jun; 11(3):386-399. PubMed ID: 35693405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
    Liu J; Zhu Q; Li Y; Qiao GL; Xu C; Guo DL; Tang J; Duan R
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):330-338. PubMed ID: 29551612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion.
    Wang YY; Wang LJ; Xu D; Liu M; Wang HW; Wang K; Zhu X; Xing BC
    HPB (Oxford); 2019 Apr; 21(4):425-433. PubMed ID: 30249510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of various interventions on the occurrence of macrovascular invasion of hepatocellular carcinoma after the baseline serum γ-glutamyltransferase stratification.
    Liu Y; Zhang Q; Yang X; Li Y; Zhu B; Niu S; Huang Y; Hu Y; Wang X
    Onco Targets Ther; 2019; 12():1671-1679. PubMed ID: 30881022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value and preoperative predictors of microvascular invasion in solitary hepatocellular carcinoma ≤ 5 cm without macrovascular invasion.
    Zhao H; Hua Y; Lu Z; Gu S; Zhu L; Ji Y; Qiu Y; Dai T; Jin H
    Oncotarget; 2017 Sep; 8(37):61203-61214. PubMed ID: 28977857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.